TY  - GEN
AU  - Salvati,F
AU  - Rasi,G
AU  - Portalone,L
AU  - Antilli,A
AU  - Garaci,E
TI  - Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial
SN  - 0250-7005
PY  - 1996///0821
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adjuvants, Immunologic
KW  - adverse effects
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - Combined Modality Therapy
KW  - Female
KW  - Humans
KW  - Ifosfamide
KW  - administration & dosage
KW  - Immunity, Cellular
KW  - drug effects
KW  - Immunotherapy
KW  - Interferon-alpha
KW  - Leukopenia
KW  - chemically induced
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Thymalfasin
KW  - Thymosin
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -